Skip to main navigation Skip to search Skip to main content

Preserved cross-bridge kinetics in human hypertrophic cardiomyopathy patients with MYBPC3 mutations

  • S.J. van Dijk
  • , N.M. Boontje
  • , M.W. Heymans
  • , F.J. ten Cate
  • , M. Michels
  • , C. dos Remedios
  • , D. Dooijes
  • , M.A. van Slegtenhorst
  • , J. van der Velden
  • , G.J.M. Stienen

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Mutations in the MYBPC3 gene, encoding cardiac myosin binding protein C (cMyBP-C) are frequent causes of hypertrophic cardiomyopathy (HCM). Previously, we have presented evidence for reduced cMyBP-C expression (haploinsufficiency), in patients with a truncation mutation in MYBPC3. In mice, lacking cMyBP-C cross-bridge kinetics was accelerated. In this study, we investigated whether cross-bridge kinetics was altered in myectomy samples from HCM patients harboring heterozygous MYBPC3 mutations (MYBPC3
Original languageEnglish
Pages (from-to)1619-1633
JournalPflügers Archiv European Journal of Physiology
Volume466
Issue number8
DOIs
Publication statusPublished - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Preserved cross-bridge kinetics in human hypertrophic cardiomyopathy patients with MYBPC3 mutations'. Together they form a unique fingerprint.

Cite this